Clinical Trial Update: tVNS in Long COVID-19 [NA]

View source ↗

Summary

A clinical trial is evaluating transcutaneous vagus nerve stimulation (tVNS) for Long COVID and chronic fatigue syndrome, with recruitment currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myalgic Encephalomyelitis Chronic Fatigue Syndrome
• Post-acute Sequelae of Sars-cov-2 Infection

Drugs mentioned

• TVNS

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Long COVID, Chronic Fatigue Syndrome | NA | Status: RECRUITING